Cargando…

Prevention of risks associated with inappropriate use/unnecessary consumption of medicines()

In the code of public health, misuse is defined as intentional and inappropriate use of a medicine or product, which is not in accordance with the terms of the marketing authorisation or the registration as well as with good practice recommendations. Very often this involves an individual or the int...

Descripción completa

Detalles Bibliográficos
Autores principales: Cracowski, Jean-Luc, Muller, Sophie, Anglade, Isabelle, Bonnefond, Gilles, Bouhanick, Béatrice, Bouquet, Sylvain, Cabut, Sandrine, Daynès, Pascale, Denis, Bernard, Durand, Dorothée, Jonville-Béra, Annie-Pierre, Lahouegue, Amir, Léo, Magali, Micallef, Joëlle, Molimard, Mathieu, Penfornis, Catherine, Querol-Ferrer, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783759/
https://www.ncbi.nlm.nih.gov/pubmed/35078658
http://dx.doi.org/10.1016/j.therap.2022.01.003
_version_ 1784638601121759232
author Cracowski, Jean-Luc
Muller, Sophie
Anglade, Isabelle
Bonnefond, Gilles
Bouhanick, Béatrice
Bouquet, Sylvain
Cabut, Sandrine
Daynès, Pascale
Denis, Bernard
Durand, Dorothée
Jonville-Béra, Annie-Pierre
Lahouegue, Amir
Léo, Magali
Micallef, Joëlle
Molimard, Mathieu
Penfornis, Catherine
Querol-Ferrer, Valérie
author_facet Cracowski, Jean-Luc
Muller, Sophie
Anglade, Isabelle
Bonnefond, Gilles
Bouhanick, Béatrice
Bouquet, Sylvain
Cabut, Sandrine
Daynès, Pascale
Denis, Bernard
Durand, Dorothée
Jonville-Béra, Annie-Pierre
Lahouegue, Amir
Léo, Magali
Micallef, Joëlle
Molimard, Mathieu
Penfornis, Catherine
Querol-Ferrer, Valérie
author_sort Cracowski, Jean-Luc
collection PubMed
description In the code of public health, misuse is defined as intentional and inappropriate use of a medicine or product, which is not in accordance with the terms of the marketing authorisation or the registration as well as with good practice recommendations. Very often this involves an individual or the interaction of several individuals including the patient, his/her carers, prescriber(s) and/or dispensers. Misuse is common; it is the source of medicinal adverse effects for which a significant part is avoidable. Medicines initially prescribed or dispensed in the context of their marketing authorization (MA) can also be the subject of primary dependency and misappropriation. Companies which develop medicines nationally make declarations to the ANSM (French National Agency for the Safety of Medicines and Health Products) and implement measures to limit non-compliant use of their products. Recently, the coronavirus disease-2019 (COVID-19) pandemic has highlighted the influence and societal impact of drug misuse. The finding of the existence of systemic misuse, the impossibility of proposing simple solutions leads us to propose two main areas for improved information and the training of users and health professionals in medicines in the context of multi-faceted interventions: prevention of misuse on the one hand and its identification and treatment on the other hand.
format Online
Article
Text
id pubmed-8783759
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique.
record_format MEDLINE/PubMed
spelling pubmed-87837592022-01-24 Prevention of risks associated with inappropriate use/unnecessary consumption of medicines() Cracowski, Jean-Luc Muller, Sophie Anglade, Isabelle Bonnefond, Gilles Bouhanick, Béatrice Bouquet, Sylvain Cabut, Sandrine Daynès, Pascale Denis, Bernard Durand, Dorothée Jonville-Béra, Annie-Pierre Lahouegue, Amir Léo, Magali Micallef, Joëlle Molimard, Mathieu Penfornis, Catherine Querol-Ferrer, Valérie Therapie Giens Workshops 2021/Health and economy In the code of public health, misuse is defined as intentional and inappropriate use of a medicine or product, which is not in accordance with the terms of the marketing authorisation or the registration as well as with good practice recommendations. Very often this involves an individual or the interaction of several individuals including the patient, his/her carers, prescriber(s) and/or dispensers. Misuse is common; it is the source of medicinal adverse effects for which a significant part is avoidable. Medicines initially prescribed or dispensed in the context of their marketing authorization (MA) can also be the subject of primary dependency and misappropriation. Companies which develop medicines nationally make declarations to the ANSM (French National Agency for the Safety of Medicines and Health Products) and implement measures to limit non-compliant use of their products. Recently, the coronavirus disease-2019 (COVID-19) pandemic has highlighted the influence and societal impact of drug misuse. The finding of the existence of systemic misuse, the impossibility of proposing simple solutions leads us to propose two main areas for improved information and the training of users and health professionals in medicines in the context of multi-faceted interventions: prevention of misuse on the one hand and its identification and treatment on the other hand. Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. 2022 2022-01-07 /pmc/articles/PMC8783759/ /pubmed/35078658 http://dx.doi.org/10.1016/j.therap.2022.01.003 Text en © 2022 Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Giens Workshops 2021/Health and economy
Cracowski, Jean-Luc
Muller, Sophie
Anglade, Isabelle
Bonnefond, Gilles
Bouhanick, Béatrice
Bouquet, Sylvain
Cabut, Sandrine
Daynès, Pascale
Denis, Bernard
Durand, Dorothée
Jonville-Béra, Annie-Pierre
Lahouegue, Amir
Léo, Magali
Micallef, Joëlle
Molimard, Mathieu
Penfornis, Catherine
Querol-Ferrer, Valérie
Prevention of risks associated with inappropriate use/unnecessary consumption of medicines()
title Prevention of risks associated with inappropriate use/unnecessary consumption of medicines()
title_full Prevention of risks associated with inappropriate use/unnecessary consumption of medicines()
title_fullStr Prevention of risks associated with inappropriate use/unnecessary consumption of medicines()
title_full_unstemmed Prevention of risks associated with inappropriate use/unnecessary consumption of medicines()
title_short Prevention of risks associated with inappropriate use/unnecessary consumption of medicines()
title_sort prevention of risks associated with inappropriate use/unnecessary consumption of medicines()
topic Giens Workshops 2021/Health and economy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783759/
https://www.ncbi.nlm.nih.gov/pubmed/35078658
http://dx.doi.org/10.1016/j.therap.2022.01.003
work_keys_str_mv AT cracowskijeanluc preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT mullersophie preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT angladeisabelle preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT bonnefondgilles preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT bouhanickbeatrice preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT bouquetsylvain preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT cabutsandrine preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT daynespascale preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT denisbernard preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT duranddorothee preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT jonvilleberaanniepierre preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT lahouegueamir preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT leomagali preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT micallefjoelle preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT molimardmathieu preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT penforniscatherine preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines
AT querolferrervalerie preventionofrisksassociatedwithinappropriateuseunnecessaryconsumptionofmedicines